ZEVEX International Sponsors Cancer and Nutrition Symposium, Expands Market Opportunity SALT LAKE CITY, July 15 /PRNewswire-FirstCall/ -- ZEVEX International, Inc., (NASDAQ:ZVXI) manufacturer and marketer of the EnteraLite(R) ambulatory enteral feeding pump, announced it was one of the major sponsors of the 11th Symposium on Nutrition and Cancer held on July 8-9, 2004, hosted by the University of Texas in Houston and the Centers for Disease Control in Atlanta. The symposium was held at MD Anderson Cancer Center at the University of Texas, which U.S. News and World Report named the leading cancer center in the U.S. for the third year in a row in its annual ranking. Clinicians who specialize in nutrition and oncology from around the globe attended the symposium. David McNally, Chairman and CEO of ZEVEX, said, "Enteral nutrition delivery for cancer patients represents a new market opportunity for ZEVEX. The initial response by clinicians at the symposium to the EnteraLite was very encouraging, and we have already begun providing EnteraLite pumps to home care cancer patients who can continue their radiation and chemotherapy treatments as outpatients. The EnteraLite brings a great improvements to these patients' quality of life through its portability and ease of use." At present, pediatric enteral nutrition consumers are the primary users of ZEVEX' EnteraLite. According to Frost & Sullivan and internal company estimates, the U.S. market for enteral nutrition delivery for feeding pumps and associated administration sets is at least $250 million annually. Current procedures for feeding cancer patients may require them to interrupt their radiation or chemotherapy treatments and report for a feeding regimen using a stationary pump. Because the ZEVEX pump is portable, patients can receive treatment, return to their normal lives and even go to work while receiving better nutrition delivery. Many patients who use the EnteraLite have reported their ability to maintain or gain weight. ABOUT ZEVEX ZEVEX International, Inc., (http://www.zevex.com/), founded in 1986, is a diversified medical device company committed to creating products that transform life with patented and proprietary medical device technologies -- from sensors and surgical tools to medical electronic systems. This article is current as of the date of original publication and is provided for historical informational purposes only. ZEVEX makes no representations that the information in this article is current as of the date the article is accessed and takes no responsibility for updating the information contained in its articles. DATASOURCE: ZEVEX International, Inc. CONTACT: Nancy E. Schultz, Director, Corporate Communications/Investor Relations, ZEVEX International, Inc., +1-801-264-1001 ext. 203, fax +1-801-264-1051, Web site: http://www.zevex.com/

Copyright

Zevex (NASDAQ:ZVXI)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Zevex 차트를 더 보려면 여기를 클릭.
Zevex (NASDAQ:ZVXI)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Zevex 차트를 더 보려면 여기를 클릭.